phospho-Tau (Thr217) Polyclonal Antibody, Cy7 Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bs-2843R-Cy7-100uL |
| Product Name | phospho-Tau (Thr217) Polyclonal Antibody, Cy7 Conjugated |
| Applications |
WB
IF
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Cy7 |
| Host | Rabbit |
| Source | KLH conjugated Synthesised phosphopeptide derived from human Tau around the phosphorylation site of Thr4217) |
| Modification Site | Thr217 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | affinity Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 4137 |
| Swiss Prot | P10636 |
| Subcellular location | Cytoplasm, Cell membrane |
| Synonyms | Tau(Phospho-Thr217); MAPT(phospho T217);Tau(Phospho-Thr217); MAPT; Microtuble-associted protein Tau; AI413597; AW045860; DDPAC; Disinhibition dementia parkinsonism amyotrophy complex; FLJ31424; FTDP 17; FTDP17; G Protein beta 1 gamma 2 subunit interacting factor 1; G protein beta1/gamma2 subunit interacting factor 1; MAPTL; MGC134287; MGC138549; MGC156663; Microtubule associated protein tau isoform 4; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; Paired helical filament tau; PHF tau; PHF-tau; PPND; pTau; RNPTAU; Tauopathy and respiratory failure, included; TAU_HUMAN. |
| Background | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. |
| Application Dilution | |
| WB | =1:500-2000 |
| IF | |
Frequently asked questions
Which applications is phospho-Tau (Thr217) Polyclonal Antibody, Cy7 Conjugated (bs-2843R-Cy7) validated for, and at what dilution?
bs-2843R-Cy7 is validated for WB (WB=1:500-2000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does phospho-Tau (Thr217) Polyclonal Antibody, Cy7 Conjugated (bs-2843R-Cy7) react with?
Tested reactivity: Human.
How should bs-2843R-Cy7 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise phospho-Tau (Thr217) Polyclonal Antibody, Cy7 Conjugated (bs-2843R-Cy7)?
KLH conjugated Synthesised phosphopeptide derived from human Tau around the phosphorylation site of Thr4217)
What are the excitation and emission wavelengths of the Cy7 conjugate (bs-2843R-Cy7)?
Cy7 on bs-2843R-Cy7: excitation / emission 743nm/767nm.